Overview

Plasmid DNA is essential to genetic engineering due to its role in molecular cloning and the production of bioengineered products, such as therapeutic proteins. Plasmid engineering involves designing, constructing and modifying plasmid DNA to carry and express a specific gene of interest within a host organism. It is a key technique in genetic engineering that enables gene cloning, protein production and therapeutic development.

Here, we explore the role of plasmid vectors and recombinant DNA in the plasmid DNA development workflow, covering their design, construction and use in gene cloning, gene amplification and cell transfection.

What is A Plasmid?

Plasmids were first found in bacteria as extrachromosomal genetic material. Plasmids are small, circular arrangements of DNA that are not integrated into an organism’s genome and can replicate independently of genomic DNA.

Plasmid DNA is mainly found in bacteria and carries genes that serve survival functions, such as antibiotic resistance and rapid replication. Plasmids have been discovered in yeasts and plants, as well as organelles of eukaryotic organisms.

Plasmids as Vectors in Genetic Engineering Applications

Finding an ideal vector for genetic engineering is integral to successfully transferring foreign genetic material into another organism and rapidly replicating it without degradation by the host. Plasmids offer several advantages, making them suitable for widespread use in biotechnology and genetic engineering.

Their relatively small backbone size makes them ideal for vector isolation and purification, while the circular structure makes them more stable and resistant to degradation than linear DNA. In addition, cloning plasmids can harbor high copy numbers in a host, leading to large numbers of extractable plasmids.

The gene of interest is amplified with primers, inserted into a plasmid by annealing to complementary sequences at a restriction site and transformed into a host, where the plasmid's origin of replication allows the inserted gene and the plasmid vector to be self-replicated separately from the host's chromosomal DNA. Other plasmid genes, particularly those conferring antibiotic resistance or fluorescence, can serve as markers to identify cells that have successfully taken up the plasmid.

Artificial plasmids can be used as vectors for recombinant protein production and gene therapy. They support the production of therapeutic proteins used to treat diseases such as cancer and autoimmune disorders. Key applications include:

• Recombinant protein production: Enables the generation of proteins such as therapeutic antibodies and antibody-drug conjugates
• Industrial-scale production: commonly used to engineer E. coli or S. cerevisiae for large-scale insulin production in diabetes treatment

Emerging and clinical applications demonstrate their therapeutic potential:

• Gene therapy development: Plasmid DNA is used to encode therapeutic genes or proteins
• Cancer research applications: Anti-HER2 monoclonal antibodies encoded by plasmid DNA have reversed tumor growth in preclinical models
• Clinical studies: Plasmid DNA encoding integrin inhibitor peptides has shown potential to counteract tumor progression in early-phase trials

Plasmid Structure

A plasmid DNA construct must contain essential sequences to exert its function.

1. Origin of replication (ORI) sequences for autonomous plasmid DNA replication
2. Antibiotic resistance gene for the selection of transfected cells on a selective medium
3. Restriction sites, also known as multicloning sites, for foreign DNA insertion using restriction enzymes
4. Promoter Region for initiating target (gene of interest) DNA transcription

Plasmid Engineering Workflow

Construction of the Plasmid DNA Cloning Vector

Plasmid construction combines a plasmid vector backbone with a foreign gene, inserting the DNA into the vector. First, a DNA fragment with the gene is isolated from its genome and the plasmid is purified.

Plasmid backbones have restriction sites. Restriction enzymes cut plasmid DNA and PCR-amplified genes at these sites, creating sticky ends. DNA ligase then joins the target gene and the plasmid DNA, forming a double-stranded circular DNA molecule.

Transforming Plasmid DNA into the Host Cell

Once plasmid DNA and the target gene are ligated, the plasmid construct is introduced into bacterial cultures like E. coli, which quickly replicate and produce it at scale. Transformation involves making bacterial cell walls more permeable to allow the plasmid to be taken up.

Common methods for permeabilizing cell membranes include heat shock and electroporation. Bacteria are treated with CaCl2, chilled to near 0 °C, then heat-shocked at about 30 °C to create pores for DNA entry. Electroporation uses electric fields to form pores, while other techniques like microinjection, bacterial conjugation and liposome-mediated transfer are used for difficult vectors or strains.

Selection

After transformation, bacteria are grown on a selective medium containing an antibiotic to select for cells carrying the plasmid and eliminate those that do not. The plasmid's antibiotic resistance gene enables this selection, with antibiotics added to the media or plates so only resistant cells survive. Lastly, the same isolation and purification methods are used again to extract plasmid constructs from the bacterial culture.

Plasmid DNA Isolation

Before using plasmid DNA for protein production, it must be harvested and separated from bacterial chromosomal DNA. One common method is Alkaline lysis, which involves pelleting bacterial cells by centrifugation and suspending them in a solution containing NaOH and SDS. This breaks cell membranes and walls.

Purification of the Plasmid DNA

DNA, including plasmid and genomic DNA, must be isolated from the solution by removing residual proteins and contaminants. Several methods exist for this purpose.

1. Phenol-chloroform mixtures help remove proteins and lipids, separating plasmid DNA from cellular debris
2. Spin columns pass the plasmid DNA solution through a solid matrix that selectively binds nucleic acids. Proteins, lipids and salts are washed away in the process
3. Plasmid DNA, like other nucleic acids, is insoluble in ethanol solutions. Ethanol induces plasmid DNA precipitation, which can be extracted from cellular debris upon centrifugation
4. Magnetic beads can bind plasmid DNA in a solution and separate it from contaminants

Verification (sequence/identity confirmation)

After purification, plasmids are isolated from genomic DNA by size using gel electrophoresis, ultracentrifugation or anion exchange chromatography. To confirm construct integrity, Sanger sequencing or NGS verifies correct gene insertion and detects mutations, which is crucial before applications like gene therapy and protein production. For details, see DNA Sequencing for Plasmids. Validated plasmids are then cell-banked and transformed into production strains for large-scale expression of bioengineered products.

Choosing the Ideal Plasmid Type as a Cloning Vector

The choice of cloning vector depends on the size of the DNA fragment to insert. In general, plasmid DNA is suitable for inserting fragments of up to 15 kbp.

Special vectors beyond plasmids are preferable when incorporating larger fragments. More importantly, they are used to generate genomic libraries employed in whole-genome sequencing of organisms for genetic engineering applications.

1. Cosmid is a plasmid with bacteriophage Cos sites enabling gene packaging into λ particles, increasing insertion capacity to 45 kbp
2. Fosmid, derived from bacterial F-plasmids, has gene partitioning mechanisms for intercellular transformation with insert sizes up to 40 kbp. Its low copy number enhances the stability of cloned DNA
3. Bacterial artificial chromosomes, derived from F-plasmids, allow gene insertion between 150-350 kbp and are extensively used for whole-genome sequencing in the Human Genome Project

Real-World Applications of Plasmid Engineering

Biopharma & Therapeutics

• Recombinant protein production (e.g., insulin, antibodies)
• Gene therapy vector development
• DNA and mRNA vaccine platforms

Drug Discovery & Research

• Functional genomics and target validation
• CRISPR guide RNA and editing tool delivery
• Disease modeling in cell lines

Industrial Biotechnology

• Engineered microbes for enzyme or metabolite production
• Synthetic biology applications